# Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

Study · id `cardio:ct-nct01067950` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01067950](<https://clinicaltrials.gov/study/NCT01067950>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01067950

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT01067950. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT01067950, source copy `cardio:ctgov-nct01067950-2010-06-02`, retrieved 2026-10-26)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01067950, source copy `cardio:ctgov-nct01067950-2010-06-02`, retrieved 2026-10-26)
- Primary completion: Not reported
- Completion: Not reported
- Countries: United States; Brazil; Czechia; France; Italy (ClinicalTrials.gov record NCT01067950, source copy `cardio:ctgov-nct01067950-2010-06-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01067950-2010-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study
- Acronym: PANCREAS
- Condition: Type 1 Diabetes
- Intervention (Procedure): Isolated Pancreas Transplant
- Intervention (Drug): Intensive Insulin Therapy
- Lead sponsor: Nantes University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Type 1 diabetes (`core:type-1-diabetes`)
- Registry lists this organization as the lead sponsor: Nantes University Hospital (`cardio:org-nantes-university-hospital`)

## Provenance

Content hash: 5f0b95713ab446961a27cf6fee63195e1060b9ecf2df5ed028d7f5202989bd84
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
